Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

McKesson (0JZU) Share Price & Analysis

1 Followers

0JZU Stock Chart & Stats

$1,075.77$11.59(0.96%)
At close: 4:30 PM GMT
$900$1KAug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
$1,040.80 - $1,095.30
52-Week Range
$710.01 - $1,116.60
Previous Close
$1,065.59
Volume
N/A
Average Volume (3M)
334
Market Cap
$124.99B
Enterprise Value
$107.12B
Total Cash (Recent Filing)
$6.53B
Total Debt (Recent Filing)
$11.16B
Price to Earnings (P/E)
27.7
Beta
0.46
Next Earnings
Feb 10, 2027 (Est.)
EPS Estimate
10.93
Next Dividend Ex-Date
Dec 01, 2026
Dividend Yield
0.32%

Bulls Say, Bears Say

Bulls Say

Cash Generation

Strong cash conversion gives McKesson internal funding for technology, operations, acquisitions, debt service, and shareholder returns. Free cash flow near net income also supports earnings quality, making the business more resilient despite its low-margin distribution model.

Broad-based Growth

Growth across all four operating segments indicates that performance is not dependent on a single product or customer category. Broad revenue and earnings expansion can strengthen operating leverage and support continued investment over the next several quarters.

Specialty-care Expansion

The Precision Medicine Group acquisition expands McKesson’s position in oncology, rare diseases, cell and gene therapies, and commercialization services. These capabilities can deepen customer relationships and diversify growth toward complex, higher-value healthcare services.

Bears Say

Leverage And Negative Equity

Negative equity and rising debt leave McKesson with a limited equity cushion and less financial flexibility if profitability weakens. Leverage also increases sensitivity to interest costs and operating setbacks, potentially constraining future investment and capital allocation.

Thin Margins

Very low distribution margins leave limited room for pricing, cost, or execution errors. Even modest pressure on purchasing economics, reimbursement, or operating efficiency could materially affect earnings, while declining margins suggest that profitability remains structurally sensitive.

MedSurg Weakness

The medical-surgical segment is producing a persistent earnings drag: management expects revenue growth but little to no operating-profit improvement. Continued margin pressure in this business could dilute stronger results elsewhere and reduce the benefit of consolidated growth.

McKesson News

0JZU FAQ

What was McKesson’s price range in the past 12 months?
McKesson lowest share price was $710.01 and its highest was $1116.60 in the past 12 months.
What is McKesson’s market cap?
McKesson’s market cap is $124.99B.
When is McKesson’s upcoming earnings report date?
McKesson’s next earnings report is estimated for Feb 10, 2027 (not yet confirmed), which is in 91 days.
How were McKesson’s earnings last quarter?
McKesson released its earnings results on Nov 04, 2026. The company reported $11.68 earnings per share for the quarter, beating the consensus estimate of $10.718 by $0.962.
Is McKesson overvalued?
According to Wall Street analysts McKesson’s price is currently Undervalued.
Does McKesson pay dividends?
McKesson pays a quarterly dividend of $0.94 which represents an annual dividend yield of 0.32%. See more information on McKesson dividends here
What is McKesson’s EPS estimate?
McKesson’s EPS estimate is 10.93.
How many shares outstanding does McKesson have?
McKesson has 115,456,665 shares outstanding.
What happened to McKesson’s price movement after its last earnings report?
McKesson reported an EPS of $11.68 in its last earnings report, beating expectations of $10.718. Following the earnings report the stock price went up 4.608%.
Which hedge fund is a major shareholder of McKesson?
Hedge funds hold McKesson shares: the largest hedge-fund position in McKesson is 757,087,020 shares, and hedge funds increased their holdings by 323.4K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology